NCT01791374 Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ Status COMPLETED Phase PHASE1
NCT01791361 Medical Records Review to Describe the Patterns of KRAS Testing and Vectibix Use in Europe Status COMPLETED Phase N/A
NCT01789242 A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis Status COMPLETED Phase PHASE1
NCT01788046 Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis Status COMPLETED Phase PHASE3
NCT01785875 Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis Status COMPLETED Phase PHASE3
NCT01785849 Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis Status COMPLETED Phase PHASE3
NCT01775553 Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib Status COMPLETED Phase PHASE2
NCT01764633 Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Status COMPLETED Phase PHASE3
NCT01763918 Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2 Status COMPLETED Phase PHASE3
NCT01763905 Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2 Status COMPLETED Phase PHASE3
NCT01763866 LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2 Status COMPLETED Phase PHASE3
NCT01763827 Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2 Status COMPLETED Phase PHASE3
NCT01755442 Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects Status TERMINATED Phase PHASE1
NCT01752907 Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim Status COMPLETED Phase PHASE2
NCT01745068 Partnership for Applied Research in Fracture Prevention Programs for the Elderly Status UNKNOWN Phase NA
NCT01744782 Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis Status COMPLETED Phase PHASE3
NCT01740297 Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT01738594 Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma Status TERMINATED Phase PHASE1
NCT01737879 Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis Status TERMINATED Phase PHASE4
NCT01733316 Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in Cystinosis Status COMPLETED Phase PHASE3